Vicki Salmon at IP asset LLP questions whether the system that is being proposed makes life easier or more difficult for technology companies, whether the political deal is a good one, and how, if it comes about, it should affect your current patenting and business strategies.
The Munich initiative m4 – Personalized Medicine and Targeted Therapies was awarded Leading-Edge cluster status by the German Federal Ministry…
Angel Biotechnology Holdings plc is a full service contract bio-manufacturing partner to biotechnology and pharmaceutical companies worldwide. Angel specialises in…
Mihajlo Ceraj Ceri, Life Sciences Director, and Marijo Volarevi, VP Business Services at Infotehna, investigate how generic drug manufacturers can benefit utilising document management solutions in managing the drug development process.
Dr. Patricia Lobo, Editor of IPI, speaks with Fran L. DeGrazio of West Pharmaceutical Services, Inc. about reducing the risk of needlestick injuries
New technologies include passive systems that allow for safer injection without altering the caregiver’s administration technique in the hospital and clinical setting.
Formulating oral dosage forms for paediatrics is very challenging due to the specificities of this patient population. Formulators face challenges like ensuring active stability, improving palatability and easing swallowing with specific dosage forms. These issues can be solved with appropriate formulation of attractive dosage forms. Cécile Dusautois of Roquette gives some indications in this article.
Active Pharmaceutical Ingredient (API) Outsourcing – a Perspective from an Integrated Drug Development Solutions Provider
The contract research and manufacturing sector is changing to meet the new demands and opportunities that the marketplace presents. Quality, customer care and delivery are baseline expectations, and new demonstration of additional delivered value at the right price is taking centre stage. In this article, Dr Austin McMordie of Almac presents the argument for effective integration as a new way to deliver outsourced services.
Dr Rüdiger Lomb of World Courier explains that “There is no ‘cookie-cutter’ approach to clinical research” and recommends that pharmaceutical practitioners select their service providers with care.